EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 351 filers reported holding EXELIXIS INC in Q2 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,253,000 | -56.4% | 411,200 | -46.9% | 0.02% | -63.3% |
| Q3 2020 | $18,917,000 | -21.1% | 773,715 | -23.2% | 0.06% | -25.0% |
| Q1 2019 | $23,973,000 | -3.6% | 1,007,275 | +23.1% | 0.08% | +12.7% |
| Q4 2017 | $24,873,000 | +25.9% | 818,178 | +0.4% | 0.07% | +22.4% |
| Q3 2017 | $19,752,000 | -72.4% | 815,175 | -72.0% | 0.06% | -72.8% |
| Q2 2017 | $71,593,000 | +11.2% | 2,906,720 | -2.2% | 0.21% | +10.4% |
| Q1 2017 | $64,396,000 | -9.3% | 2,971,659 | -37.6% | 0.19% | -10.6% |
| Q4 2016 | $71,035,000 | -7.0% | 4,764,269 | -20.2% | 0.22% | -7.3% |
| Q3 2016 | $76,374,000 | +236.6% | 5,971,377 | +105.5% | 0.23% | +228.2% |
| Q2 2016 | $22,690,000 | – | 2,905,222 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |